Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Adi Diab, MD
Woman and Man Max 99 years
Adi Diab, MD
Update Il y a 4 ans
APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
The goal of Part 1 of this clinical research study is to find the highest tolerable dose of APX005M that can be given with pembrolizumab that can be given to patients with metastatic melan...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Adi Diab, MD
Update Il y a 4 ans
Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma
The goal of this clinical research study is to find the highest tolerated dose of rAd.CD40L (also called ISF35) when given with pembrolizumab to patients with melanoma. Researchers also wa...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Adi Diab, MD
Update Il y a 4 ans
Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma
The goal of this clinical research study is to learn if the combination of ipilimumab and ABI-007 (abraxane) can help to control metastatic melanoma. The safety of this drug combination wi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Adi Diab, MD
Update Il y a 4 ans
Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4
The goal of this clinical research study is to learn about the safety of giving CD8+T cells with ipilimumab, cyclophosphamide, and IL-2 (aldesleukin). Researchers also want to learn if thi...
Country
None
organs
None
Specialty
None
Opened trial
More information